AFRM(AFRM)
AFRM
Q3 2026 EPS Estimate
$0.35
Aug 27, 2026 · Reports after close
Revenue Estimate
$1.11B
FY2027E EPS$1.80
FY2028E EPS$2.58
Analyst Sentiment
Wall St. Consensus
Buy30 analysts·High coverage
68
Score
22 Buy (73%)7 Hold (23%)1 Sell (4%)
Rating Breakdown
Strong Buy
00%
Buy
2273%
Hold
723%
Sell
13%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$75.00
-4.3%
Consensus
$92.00
+17.4%
Bull
$106.00
+35.3%
12-Month Target Range30 analysts
$75.00$92.00$106.00
Current $78.35Consensus
Current Price
$78.35
Upside to Consensus
$13.65
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+25.54%
EPS+43.85%
FY2028
Rev+24.84%
EPS+43.57%
FY2029
Rev+23.79%
EPS+45.95%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $5.28B | $6.59B | $8.15B | $17.00B |
| Low | $5.08B | $6.13B | $7.42B | $15.92B |
| High | $5.59B | $7.03B | $8.93B | $18.28B |
| EBITDA Avg | $-1.13B | $-1.42B | $-1.75B | $-3.66B |
| Low | $-1.20B | $-1.51B | $-1.92B | $-3.93B |
| High | $-1.09B | $-1.32B | $-1.60B | $-3.42B |
| EBIT Avg | $-1.44B | $-1.80B | $-2.23B | $-4.64B |
| Low | $-1.53B | $-1.92B | $-2.44B | $-4.99B |
| High | $-1.39B | $-1.67B | $-2.03B | $-4.34B |
| Net Income Avg | $633M | $900M | $1.29B | $1.40B |
| Low | $475M | $623M | $1.16B | $1.28B |
| High | $792M | $1.18B | $1.41B | $1.54B |
| EPS Avg | $1.80 | $2.58 | $3.77 | $4.11 |
| Low | $1.39 | $1.83 | $3.39 | $3.77 |
| High | $2.32 | $3.45 | $4.13 | $4.51 |
| Analysts (Rev / EPS) | 25 / 16 | 23 / 22 | 11 / 10 | 8 / 8 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.16B | $1.39B | $1.30B | $1.42B | $1.47B | $1.72B | $1.62B | $1.76B |
| Low | $1.14B | $1.35B | $1.26B | $1.38B | $1.43B | $1.67B | $1.57B | $1.70B |
| High | $1.19B | $1.45B | $1.35B | $1.48B | $1.53B | $1.79B | $1.68B | $1.83B |
| EBITDA Avg | $-250M | $-299M | $-280M | $-305M | $-316M | $-371M | $-347M | $-378M |
| Low | $-256M | $-311M | $-291M | $-318M | $-329M | $-386M | $-362M | $-393M |
| High | $-245M | $-290M | $-271M | $-296M | $-307M | $-359M | $-337M | $-366M |
| EBIT Avg | $-317M | $-379M | $-355M | $-387M | $-401M | $-470M | $-441M | $-479M |
| Low | $-325M | $-395M | $-370M | $-403M | $-418M | $-490M | $-459M | $-499M |
| High | $-311M | $-368M | $-344M | $-375M | $-389M | $-456M | $-428M | $-465M |
| Net Income Avg | $121M | $181M | $142M | $179M | $187M | $254M | $198M | $245M |
| Low | $88M | $174M | $136M | $172M | $179M | $244M | $191M | $235M |
| High | $161M | $191M | $149M | $188M | $197M | $268M | $209M | $258M |
| EPS Avg | $0.35 | $0.52 | $0.41 | $0.51 | $0.54 | $0.73 | $0.57 | $0.70 |
| Low | $0.25 | $0.50 | $0.39 | $0.49 | $0.52 | $0.70 | $0.55 | $0.68 |
| High | $0.46 | $0.55 | $0.43 | $0.54 | $0.57 | $0.77 | $0.60 | $0.74 |
| Analysts (Rev / EPS) | 15 / 5 | 10 / 1 | 7 / 1 | 7 / 3 | 7 / 3 | 7 / 1 | 6 / 2 | 13 / 4 |